Drug Shortage Report for TELMISARTAN
Report ID | 72124 |
Drug Identification Number | 02390353 |
Brand name | TELMISARTAN |
Common or Proper name | TELMISARTAN |
Company Name | SIVEM PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | TELMISARTAN |
Strength(s) | 80MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30 |
ATC code | C09CA |
ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | 2019-01-31 |
Actual start date | 2019-01-30 |
Estimated end date | 2019-07-05 |
Actual end date | 2019-07-04 |
Shortage status | Resolved |
Updated date | 2019-07-05 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-01-14 | English | Compare |